您当前的位置：
首页 >
文章列表页 >
Computer-aided design of a novel HER2-targeted cyclic peptide PET probe and its evaluation for noninvasive imaging of breast cancer
Article | 更新时间：2026-01-15

    • Computer-aided design of a novel HER2-targeted cyclic peptide PET probe and its evaluation for noninvasive imaging of breast cancer

    • “The latest research found that [68Ga] Ga-DOTA-Cyclo-WK9 peptide tracer can detect HER2 expression sensitively and specifically, providing a new method for early diagnosis and prognosis evaluation of breast cancer.”
    • Oncoradiology   Vol. 34, Issue 6, Pages: 643-654(2025)

    • DOI：10.19732/j.cnki.2096-6210.2025.06.011    

      CLC： R737.9;R445.6

    • Received：09 June 2025，

      Revised：2025-08-25，

      Published：28 December 2025

    移动端阅览

  • GUO Xu, GAO Xiaomin, YAO Ying. Computer-aided design of a novel HER2-targeted cyclic peptide PET probe and its evaluation for noninvasive imaging of breast cancer[J]. Oncoradiology, 2025, 34(6): 643-654. DOI： 10.19732/j.cnki.2096-6210.2025.06.011.

  •  
  •  

0

Views

2

下载量

0

CNKI被引量

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

The diagnostic value of quantitative and qualitative parameters of STE and SE in BI-RADS 4 breast lesions and their correlation with HER2 expression
Progress of targeted nuclide probes in guiding clinical diagnosis and treatment of breast cancer
Application progress of integrated PET/MRI in the diagnosis and treatment of breast cancer
Application progress of  68 Ga/ 18 F labeled PSMA in the diagnosis and treatment of solid tumors other than prostate cancer
Advance of PET radiomics on breast cancer

Related Author

Qiang KE
Xiaofang LIU
Jiayi REN
Chao WANG
Wu CHEN
PEI Yifei
BAI Jingwen
ZHU Hua

Related Institution

School of Medical Imaging, Shanxi Medical University
Department of Ultrasound Imaging, The First Hospital of Shanxi Medical University
Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer, School of Medicine, Xiamen University
Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals National Medical Products Administration, Beijing Key Laboratory of Carcinogenesis and Translational Research
Department of Thyroid and Breast Surgery, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region
0